Sami Labs Limited
Records under this name other than the patents Sami Labs Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 60 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,913,809 | Anti-cancer activity of (E)-1-(3′,4′-dimethoxyphenyl) butadiene Lapsed on the fee record Ended Mar 13, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 13, 2026 | From the USPTO record |
| US 9,833,422 | Anti-cancer activity of (E)-1-(3′,4′-dimethoxyphenyl)butadiene Lapsed on the fee record Ended Dec 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 5, 2025 | From the USPTO record |
| US 7,202,270 | Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses Term ended Term ended Aug 11, 2025 · From the USPTO record | Term ended | Term ended Aug 11, 2025 | From the USPTO record |
| US 9,717,766 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof Lapsed on the fee record Ended Aug 1, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 1, 2025 | From the USPTO record |
| US 9,681,666 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof Lapsed on the fee record Ended Jun 20, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 20, 2025 | From the USPTO record |
| US 9,635,862 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof Lapsed on the fee record Ended May 2, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 2, 2025 | From the USPTO record |
| US 8,383,594 | Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals Lapsed on the fee record Ended Feb 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 26, 2025 | From the USPTO record |
| US 7,217,546 | Commercially viable process for high purity of fatty alcohol C24 to C36 and its cosmetic application for skin hair and nails Term ended Term ended Nov 30, 2024 · From the USPTO record | Term ended | Term ended Nov 30, 2024 | From the USPTO record |
| US 7,582,314 | Compositions and methods for the management of hyperproliferative dermatological conditions Term ended Term ended Oct 18, 2024 · From the USPTO record | Term ended | Term ended Oct 18, 2024 | From the USPTO record |
| US 9,458,075 | Process for the manufacture of 3′-hydroxy pterostilbene Lapsed on the fee record Ended Oct 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2024 | From the USPTO record |